What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose that Elevance Health's officers will be meeting with securities analysts and investors and intend to reaffirm the company's previously stated earnings expectations from a February 6, 2002 press release and conference call.

What are the key risks highlighted by Elevance Health in this filing?

Elevance Health highlights several risks that could cause actual results to differ materially from forward-looking statements. These include trends in healthcare costs and utilization, the ability to secure premium rate increases, competitor pricing, increased government regulation, significant competitor actions, the impact of new drugs and technology, financial strength rating changes, litigation, provider contracting, and general economic downturns.

Should investors rely solely on the confirmation of earnings expectations mentioned in this report?

No, investors should not rely solely on this confirmation. The company explicitly cautions readers to consider the various risks and uncertainties that could affect actual results. They also advise reviewing other periodic reports filed with the SEC, such as Form 10-K and 10-Q, for a comprehensive understanding of the factors affecting the business.

Does this filing provide updated financial numbers or guidance?

This filing does not provide new or updated financial numbers or specific guidance. Instead, it serves as a notice that company officers will reaffirm existing earnings expectations during upcoming meetings with investors and analysts.

ELV 8-K SEC Disclosure

Summary

This 8-K filing from Elevance Health, Inc. (formerly Anthem, Inc.) on March 4, 2002, primarily serves to inform investors about upcoming meetings between company officers and securities analysts and investors. During these meetings, the company expects to reaffirm its ability to meet the earnings expectations previously provided in a press release and conference call on February 6, 2002. This confirmation suggests a level of confidence from management in the company's financial performance and outlook for the period. Investors should note that the filing reiterates the forward-looking nature of certain statements made by the company, highlighting potential risks and uncertainties that could impact actual results. These include factors such as healthcare cost trends, premium rate adjustments, competitive pricing, regulatory changes, and economic conditions. The company also advises readers to consult its previously filed documents for a comprehensive understanding of these risks.

Key Highlights

1Elevance Health (Anthem) expects to confirm previously issued earnings guidance during meetings with analysts and investors in the week of March 4, 2002.
2The company's management expresses confidence in meeting its earnings expectations established on February 6, 2002.
3This filing is a Regulation FD disclosure, ensuring that material information is broadly disseminated.
4The company explicitly states that its forward-looking statements are subject to risks and uncertainties.
5Key risk factors mentioned include healthcare cost trends, premium rate increases, competitor pricing, and government regulation.
6Other risks cited are significant acquisitions/divestitures by competitors, new drug/technology utilization, financial strength rating downgrades, litigation, provider contracting, and economic downturns.
7Elevance Health cautions investors against undue reliance on these forward-looking statements and directs them to review other SEC filings for a full picture of business risks.

Elevance Health, Inc. 8-K Report (Mar 4, 2002)

Summary

Key Highlights

Frequently Asked Questions